SCHEMBL360830

SCHEMBL360830

CCCCOC(=O)N1CCC(Br)c2nc(-c3ccc(C)cc3)c(-c3ccc(C)cc3)nc21

nearest known ligand 0.37

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 4/20 0.37
▸ KMT2A Q03164 4/20 0.37
▸ POLB P06746 2/20 0.37
▸ ADRB2 P07550 1/20 0.37
▸ ALDH1A1 P00352 1/20 0.35
▸ LMNA P02545 1/20 0.35
▸ MAPK1 P28482 1/20 0.35
▸ SMYD3 Q9H7B4 1/20 0.34
▸ ADORA3 P0DMS8 1/20 0.33
▸ ADORA1 P30542 1/20 0.33
▸ MIF P14174 1/20 0.33
▸ KDM4E B2RXH2 1/20 0.33
▸ ATM Q13315 1/20 0.33
▸ KDM1A O60341 3/20 0.33
▸ FKBP1A P62942 1/20 0.33
▸ HTR1B P28222 1/20 0.33
▸ HTR2B P41595 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL360969 0.86 MEN1 (0.36) MEN1KMT2APOLBADRB2ALDH1A1
SCHEMBL362961 0.82 GPR119 (0.41) KMT2ALMNAKDM1A
SCHEMBL362106 0.82 POLB (0.35) MEN1KMT2APOLBADRB2ALDH1A1
SCHEMBL14876636 0.81 KDM1A (0.38) MEN1KMT2AALDH1A1KDM4EKDM1A
SCHEMBL15110449 0.70 GPR119 (0.41) KMT2ALMNAKDM1A
SCHEMBL15110882 0.69 KDM1A (0.38) MEN1KMT2AALDH1A1LMNAMAPK1
SCHEMBL5804495 0.65 TARBP2 (0.44) POLBALDH1A1LMNAMAPK1ADORA3
SCHEMBL15110494 0.64 ALDH1A1 (0.41) MEN1KMT2AALDH1A1
SCHEMBL8482742 0.63 KDM5C (0.56) MEN1KMT2APOLBADRB2ALDH1A1
SCHEMBL14876725 0.63 ALDH1A1 (0.38) ALDH1A1KDM4EKDM1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2593452-A1 IP RECEPTOR AGONIST HETEROCYCLIC COMPOUNDS Novartis AG (CH) 2013-05-22 — — EP disclosed
WO-2012007539-A9 IP RECEPTOR AGONIST HETEROCYCLIC COMPOUNDS NOVARTIS AG (CH) 2012-11-01 — — WO disclosed
WO-2012007539-A1 IP RECEPTOR AGONIST HETEROCYCLIC COMPOUNDS NOVARTIS AG (CH) 2012-01-19 — — WO disclosed
Send feedback